Fitch: Sanofi's Ablynx Acquisition Reinforces Negative Rating Outlook - Fitch Research

Fitch: Sanofi's Ablynx Acquisition Reinforces Negative Rating Outlook

Fitch: Sanofi's Ablynx Acquisition Reinforces Negative Rating Outlook - Fitch Research
Fitch: Sanofi's Ablynx Acquisition Reinforces Negative Rating Outlook
Published Jan 30, 2018
1702 words — Published Jan 30, 2018
Price US$ 149.00  |  Buy this Report Now

About This Report

  
Brief Excerpt:

Fitch: Sanofi's Ablynx Acquisition Reinforces Negative Rating Outlook 30 Jan 2018 4:31 PM (EST) {COMPANYDESC_ORIGIN_PUBDATE}: Fitch Ratings says Sanofi SA's acquisition of Ablynx has reinforced the Negative Outlook on the pharmaceutical...

  
Report Type:

Press Release

Company(ies)
Ticker(s)
Format:
HTML HTML
Buy Now

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author


Cite this Report

  
MLA:
Fitch Research. "Fitch: Sanofi's Ablynx Acquisition Reinforces Negative Rating Outlook" Jan 30, 2018. Alacra Store. May 13, 2025. <http://www.alacrastore.com/fitch-credit-research/Fitch-Sanofi-s-Ablynx-Acquisition-Reinforces-Negative-Rating-Outlook-1035755_pr_frame>
  
APA:
Fitch Research. (). Fitch: Sanofi's Ablynx Acquisition Reinforces Negative Rating Outlook Jan 30, 2018. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/fitch-credit-research/Fitch-Sanofi-s-Ablynx-Acquisition-Reinforces-Negative-Rating-Outlook-1035755_pr_frame>
  
US$ 149.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.